Using Advanced Flow Cytometry for Antibody Discovery and Immuno-oncology
Discover how the iQue® platform enables multiplexed assays that deliver actionable results.
Cell-based screening assays are essential to drug discovery and development. However, conventional analytical technologies may not achieve desired speeds and throughputs. Multiplexing, the ability to evaluate multiple parameters in parallel, is essential. The iQue® Advanced Flow Cytometry Platform integrates high-throughput data acquisition and powerful analysis software to enable multiplexed assays that deliver not only faster results, but more detailed insights.
